chloroquine has been researched along with cgp-56697 in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.52) | 18.2507 |
| 2000's | 8 (17.39) | 29.6817 |
| 2010's | 23 (50.00) | 24.3611 |
| 2020's | 12 (26.09) | 2.80 |
| Authors | Studies |
|---|---|
| Gathmann, I; Jiao, X; Li, XW; Liu, GY; Royce, C; Shan, CO; Zhao, X | 1 |
| Abdulla, S; Beck, HP; Felger, I; Hatz, C; Irion, A; Mull, R; Smith, T; Tanner, M | 1 |
| Abdulla, S; Beck, HP; Gathmann, I; Hatz, C; Kibatala, P; Mull, R; Royce, C; Schellenberg, D; Tanner, M | 1 |
| Bhatt, AD; Chogle, AR; Dalvi, SS; Garg, MR; Gathmann, I; Gogtay, NJ; Kshirsagar, NA; Marathe, SN; Moorthy, NS; Mull, R; Sane, SP; Sorabjee, JS; Tilve, GH | 1 |
| Dalvi, SS; Desai, S; Gogtay, NJ; Kadam, VS; Kamtekar, KD; Kshirsagar, NA | 1 |
| Hamer, DH; Ndhlovu, M; Rowe, AK; Snow, RW; Thea, DM; Zurovac, D | 1 |
| Nakazibwe, C | 1 |
| Malekela, DA; Tarimo, DS | 1 |
| Bissagnene, E; Die-Kakou, H; Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJ | 1 |
| Haule, AF; Minzi, OM | 1 |
| Björkman, A; Fidock, DA; Gil, JP; Mårtensson, A; Petersen, I; Premji, Z; Sisowath, C; Veiga, MI | 1 |
| Oguonu, T; Okafor, HU; Shu, EN | 1 |
| Akala, HM; Bedno, SA; Coldren, RL; Eyase, FL; Moss, WJ; Prigge, ST; Spalding, MD; Waters, NC | 1 |
| Björkman, A; Blessborn, D; Kofoed, PE; Rodrigues, A; Rombo, L; Thoft-Nielsen, R; Ursing, J | 1 |
| Bergqvist, Y; Ringwald, P; Teklehaimanot, A; Yohannes, AM | 1 |
| Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Cozens, S; Dow, GS; Gettayacamin, M; Hansukjariya, P; Imerbsin, R; Kenworthy, D; Komcharoen, S; Kyle, D; Milhous, W; Miller, A; Ohrt, C; Sattabongkot, J; Veazey, J | 1 |
| Berger, F; Bertani, S; Bouchier, C; Ekala, MT; Legrand, E; Mercereau-Puijalon, O; Meynard, JB; Musset, L; Péneau, J; Volney, B; Yrinesi, J | 1 |
| Petersen, E; Schlagenhauf, P | 1 |
| Chongsuvivatwong, V | 1 |
| Alifrangis, M; Bygbjerg, IC; Charlwood, D; Hansson, HH; Madsen, LB; Thomsen, TT; Tomás, EV | 1 |
| Arinaitwe, E; Baliraine, FN; Conrad, MD; Dorsey, G; Greenhouse, B; Kamya, M; Mbogo, GW; Nankoberanyi, S; Nsobya, SL; Rosenthal, PJ; Staedke, SG; Tappero, J; Tukwasibwe, S | 1 |
| Ansah, P; Chandra, R; Djimde, AA; Ogutu, B; Penali, LK; Robbins, J; Sagara, I; Sie, A; Tiono, AB; Zhao, Q | 1 |
| Abreha, T; Alemayehu, BH; Assef, A; Auburn, S; Chatfield, MD; Chenet, SM; Dissanayake, G; Girma, S; Hwang, J; Jima, D; Kachur, SP; Kassa, M; Kebede, A; Landman, KZ; Lucchi, NW; Malone, JL; Mekasha, A; Melaku, Z; Price, RN; Shi, YP; Solomon, H; Tadesse, Y; Teka, H; Thriemer, K; Udhayakumar, V; von Seidlein, L; Zhou, Z | 1 |
| Bhagavathula, AS; Gebreyohannes, EA; Seid, MA; Tegegn, HG | 1 |
| Betuela, I; Felger, I; Hofmann, NE; Karl, S; Kinboro, B; Lorry, L; Mueller, I; Robinson, LJ; Silkey, M; Wampfler, R | 1 |
| Hai, F; Islam, S | 1 |
| Anstey, NM; Barber, BE; Chandna, A; Grigg, MJ; Menon, J; Patel, K; Price, RN; Rajahram, GS; Schimann, E; Wilkes, CS; William, T; Yeo, TW | 1 |
| Anvikar, A; Goomber, S; Mishra, N; Valecha, N; Yadav, CP | 1 |
| Asua, V; Conrad, MD; Dorsey, G; Kamya, MR; Kigozi, SP; Legac, J; Nsobya, SL; Rosenthal, PJ; Vinden, J | 1 |
| Bierhoff, M; Grobusch, MP; van Gool, T; van Hattem, JM; van Vugt, M; Visser, BJ | 1 |
| Obiebi, IP | 1 |
| Abebe, D; Ashine, T; Behaksra, S; Belachew, M; Bousema, T; Chali, W; Drakeley, C; Gadisa, E; Hailemeskel, E; Keffale, M; Mamo, H; Menberu, T; Mohammed, H; Petros, B; Shitaye, G; Shumie, G; Tadesse, FG | 1 |
| Adams, M; Avery, VM; Ballard, E; Chalon, S; Collins, KA; Elliott, S; Khoury, D; Lucantoni, L; McCarthy, JS; Mitchell, H; Moehrle, JJ; Odedra, A; Rampton, M; Robinson, GJ; Shelper, TB; Wang, CY | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Adriko, J; Ajayi, CO; Kagoro, GR; Nuwagira, C; Ogwang, PE; Olet, EA; Peter, EL; Tolo, CU | 1 |
| Bamadio, A; Djimde, AA; Doumbo, OK; Grivoyannis, A; Maiga, H; Plowe, CV; Sagara, I; Sanogo, K; Tolo, Y; Traore, A; Traore, K; Traore, OB; Traore, ZI | 1 |
| Biering-Sørensen, T; Brainin, P; de Souza, RM; Dominguez, H; Gomes, LC; Holm, AE; Hviid, L; Kaagaard, MD; Lima, KO; Marinho, CRF; Matos, LO; Silvestre, OM; Vestergaard, LS; Vieira, IVM; Wegener, A | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Alemayehu, GS; Dinka, H; Golassa, L; Hassen, J | 1 |
| Chenet, SM; Cortés, LJ; Guerra, AP; Lucchi, NW; Macedo de Oliveira, A; Olivera, MJ | 1 |
| Abuaku, B; Afrane, Y; Amoah, LE; Cui, L; Duah-Quashie, NO; Duan, M; Huang, Y; Li, X; Pan, M; Qin, Y; Sun, K; Wang, X; Yang, Q; Yang, Z; Zeng, W; Zhao, H; Zhao, W; Zhou, L; Zhu, W | 1 |
| Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G | 1 |
| Adeyemi, OS; Elebiyo, TC; Oluba, OM | 1 |
4 review(s) available for chloroquine and cgp-56697
| Article | Year |
|---|---|
Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria; Mefloquine; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Anti-malarial treatment outcomes in Ethiopia: a systematic review and meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Failure | 2017 |
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
15 trial(s) available for chloroquine and cgp-56697
| Article | Year |
|---|---|
Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; China; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Time Factors; Treatment Outcome | 1997 |
Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children.
Topics: Acute Disease; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Sesquiterpenes; Tanzania; Time Factors; Treatment Outcome | 1998 |
Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
Topics: Acute Disease; Administration, Oral; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Tanzania; Treatment Outcome | 1998 |
A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Double-Blind Method; Drug Combinations; Electrocardiography; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Polymerase Chain Reaction; Sesquiterpenes; Time Factors | 2000 |
In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.
Topics: Alleles; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Selection, Genetic; Sulfadoxine | 2009 |
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome | 2010 |
Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
Topics: Adolescent; Amino Acid Substitution; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood Chemical Analysis; Child; Child, Preschool; Chloroquine; Chromatography, High Pressure Liquid; DNA, Protozoan; Drug Combinations; Ethanolamines; Female; Fluorenes; Guinea-Bissau; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Mutation, Missense; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Treatment Outcome | 2011 |
Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Malaria, Vivax; Male; Plasmodium vivax | 2011 |
Effects of malaria volunteer training on coverage and timeliness of diagnosis: a cluster randomized controlled trial in Myanmar.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Community Health Workers; Drug Combinations; Education, Medical; Ethanolamines; Female; Fluorenes; Health Services Research; Human Experimentation; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Myanmar; Professional Competence; Time Factors; Young Adult | 2012 |
Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study.
Topics: Africa South of the Sahara; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Azithromycin; Child; Child, Preschool; Chloroquine; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male | 2015 |
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Infant; Malaria, Vivax; Male; Plasmodium vivax; Primaquine; Young Adult | 2017 |
Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Chloroquine; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Liver; Malaria, Falciparum; Malaria, Vivax; Male; Multivariate Analysis; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Primaquine; Recurrence; Regression Analysis; Risk Factors | 2017 |
Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Malaria; Malaysia; Male; Middle Aged; Plasmodium knowlesi; Treatment Outcome; Young Adult | 2018 |
A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions.
Topics: Adolescent; Adult; Animals; Anopheles; Artemether, Lumefantrine Drug Combination; Chloroquine; Female; Humans; Malaria, Vivax; Male; Middle Aged; Models, Biological; Pilot Projects; Plasmodium vivax | 2020 |
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2022 |
27 other study(ies) available for chloroquine and cgp-56697
| Article | Year |
|---|---|
A cost-effectiveness analysis of three antimalarial treatments for acute, uncomplicated Plasmodium falciparum malaria in Mumbai, India.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Combinations; Economics, Pharmaceutical; Ethanolamines; Female; Fluorenes; Hospitalization; Humans; India; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 2003 |
Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
Topics: Ambulatory Care; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Chloroquine; Cross-Sectional Studies; Drug Combinations; Drug Prescriptions; Ethanolamines; Fluorenes; Health Policy; Humans; Malaria; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Zambia | 2005 |
Treating malaria at home in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Caregivers; Chloroquine; Developing Countries; Diagnostic Errors; Drug Combinations; Drug Resistance, Viral; Ethanolamines; Fluorenes; Health Services Accessibility; Home Nursing; Humans; Malaria; Measles; Pyrimethamine; Sulfadoxine; Uganda | 2006 |
Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Attitude of Health Personnel; Chloroquine; Clinical Competence; Cross-Sectional Studies; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Guideline Adherence; Health Policy; Humans; Interviews as Topic; Malaria; Male; Middle Aged; Pyrimethamine; Sulfadoxine; Tanzania; Urban Health | 2007 |
Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Cross-Sectional Studies; Decision Making; Drug Combinations; Ethanolamines; Fluorenes; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Interviews as Topic; Malaria; Medication Systems; Pharmacies; Practice Guidelines as Topic; Private Sector; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Tanzania | 2008 |
Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Codon; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Folic Acid Antagonists; Genotype; Humans; Inhibitory Concentration 50; Kenya; Malaria; Mutation, Missense; Parasitic Sensitivity Tests; Plasmodium; Prevalence; Protozoan Proteins; Pyrimethamine; Quinolones; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2010 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Topics: Aminoquinolines; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Chromatography, Liquid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Macaca mulatta; Malaria; Male; Mass Spectrometry; Mefloquine; Plasma; Plasmodium cynomolgi; Primate Diseases; Quinine; Treatment Outcome | 2011 |
Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.
Topics: Aminoquinolines; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evolution, Molecular; Fluorenes; French Guiana; Gene Dosage; Haplotypes; Humans; Inhibitory Concentration 50; Longitudinal Studies; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Practice Guidelines as Topic; Protozoan Proteins; Quinine | 2012 |
Standby emergency treatment of malaria in travelers: experience to date and new developments.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Chloroquine; Diagnostic Tests, Routine; Drug Combinations; Emergency Treatment; Ethanolamines; Female; Fluorenes; Geography; Guidelines as Topic; Health Policy; Humans; Malaria; Plasmodium; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Sensitivity and Specificity; Travel; Travel Medicine | 2012 |
Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mozambique; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Selection, Genetic; Time Factors | 2013 |
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Markers; Humans; Infant; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors; Uganda | 2014 |
Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Atovaquone; Chloroquine; Communicable Diseases, Imported; Drug Combinations; Emigrants and Immigrants; Humans; Infant; Liberia; Malaria; Male; Plasmodium malariae; Proguanil; Recurrence; Treatment Outcome; United States | 2018 |
Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bangladesh; Chloroquine; Drug Combinations; Drug Resistance; Erythrocytes; Gene Expression; Haplotypes; Humans; India; Lumefantrine; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Myanmar; Phylogeny; Phylogeography; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Sulfadoxine | 2018 |
Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Aspartic Acid Endopeptidases; Child; Chloroquine; Drug Resistance; Folic Acid Antagonists; Humans; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Quinolines; Uganda | 2019 |
[The treatment of malaria].
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Malaria Vaccines; Male; Netherlands; Pregnancy; Travel | 2019 |
Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Resistance, Microbial; Female; Guideline Adherence; Health Policy; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinine; Surveys and Questionnaires; Young Adult | 2019 |
Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
Topics: Adolescent; Adult; Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Child; Chloroquine; Drug Resistance; Endemic Diseases; Ethiopia; Female; Haplotypes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Plasmodium vivax; Point Mutation; Polymorphism, Genetic; Prevalence; Protozoan Proteins; Young Adult | 2019 |
Developmental stages influence in vivo antimalarial activity of aerial part extracts of Schkuhria pinnata.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Asteraceae; Chloroquine; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Malaria; Male; Mice; Parasitemia; Plant Components, Aerial; Plant Extracts; Plasmodium berghei; Uganda | 2021 |
Selection of
Topics: Alleles; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins | 2021 |
Frequency of Electrocardiographic Alterations and Pericardial Effusion in Patients With Uncomplicated Malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Brazil; Case-Control Studies; Chloroquine; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Pericardial Effusion; Primaquine; Prospective Studies; Sensitivity and Specificity; Tachycardia, Ventricular | 2022 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Genotype; Health Facilities; Humans; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins | 2022 |
Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Codon; Colombia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine | 2022 |
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Ghana; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine | 2022 |
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |
Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Chloroquine; Chromolaena; Malaria; Mice; Plant Extracts | 2023 |